Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CinRx Pharma

Explore full profile

Developing novel therapeutics that address diverse therapeutic areas

Cincinnati, United StatesFounded 2015Biotech & Life Sciences
Valuation $250–500M Last recorded · 2024
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for CinRx Pharma and the history behind them.

About CinRx Pharma

CinRx is a biotechnology company that leverages its impressive industry experience to develop therapeutics in a novel way that meets the modern paradigm of drug development. The company operates in the pharmaceutical and biotech market, focusing on accelerating drug development programs to achieve marketing approval or facilitate a successful commercial exit. CinRx serves clients ranging from small biotech startups to large pharmaceutical companies, acting as both an operational and financial syndication partner. The business model revolves around providing comprehensive preclinical, clinical pharmacology, medical, biostatistical, and regulatory expertise. CinRx makes money through partnerships, clinical trial management, and successful exits of drug development programs. The company has a proven track record with 70 NDAs, 250 IND CTAs IMPDs, 36 patents, and 2,300 clinical trials.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
Cincinnati, United States
Employees
16
Open positions
None listed
Dealroom signal
64.9/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, Woman Founder, DT and LS, science-based
Business model
Manufacturing
Investment activity
3 companies, latest May 2024
Capital deployed
$202M
Preferred round
SERIES B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing May 2024 $73M $292M Undisclosed ↗
SERIES BOther financing Nov 2017 $10M $40M Undisclosed ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

CinRx Pharma website traffic

Latest recorded traffic for CinRx Pharma is 80 monthly website visits, down 96.8% over the last three months. CinRx Pharma's team declined 11.1% over the past year.

Latest monthly visits80 3-month web change-96.8% 1-year team growth-11.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States94.1%
🇮🇱 Israel5.9%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about CinRx Pharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CinRx Pharma’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.